Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates

The Ebola virus (EBOV) outbreak in West Africa during 2013–2016 demonstrated the need to improve Ebola virus disease (EVD) diagnostics and standards of care. This retrospective study compared laboratory values and clinical features of 3 nonhuman primate models of lethal EVD to assess associations wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Reisler, Ronald B., Yu, Chenggang, Donofrio, Michael J., Warren, Travis K., Wells, Jay B., Stuthman, Kelly S., Garza, Nicole L., Vantongeren, Sean A., Donnelly, Ginger C., Kane, Christopher D., Kortepeter, Mark G., Bavari, Sina, Cardile, Anthony P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547776/
https://www.ncbi.nlm.nih.gov/pubmed/28726603
http://dx.doi.org/10.3201/eid2308.170029
Descripción
Sumario:The Ebola virus (EBOV) outbreak in West Africa during 2013–2016 demonstrated the need to improve Ebola virus disease (EVD) diagnostics and standards of care. This retrospective study compared laboratory values and clinical features of 3 nonhuman primate models of lethal EVD to assess associations with improved survival time. In addition, the study identified laboratory values useful as predictors of survival, surrogates for EBOV viral loads, and triggers for initiation of therapeutic interventions in these nonhuman primate models. Furthermore, the data support that, in nonhuman primates, the Makona strain of EBOV may be less virulent than the Kikwit strain of EBOV. The applicability of these findings as potential diagnostic and management tools for EVD in humans warrants further investigation.

Ejemplares similares